Angiodynamics (ANGO) Current Assets (2011 - 2026)

Angiodynamics (ANGO) has reported Current Assets for 16 consecutive years, with $163.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 2.93% year-over-year to $163.4 million; the trailing twelve-month figure through May 2026 stood at $163.4 million (down 2.93% YoY), and the FY2026 full-year result was $163.4 million, down 2.93% from the prior year.
• Current Assets rose to $163.4 million in Q2 2026 per ANGO's latest filing, from $155.6 million in the prior quarter.
• Across five years, Current Assets topped out at $196.9 million in Q1 2024 and bottomed at $127.7 million in Q1 2022.
• Historically, Current Assets has averaged $165.2 million across 5 years, with a median of $163.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Assets climbed 29.06% in 2024, then retreated 12.9% in 2025.
• Over 5 years, Current Assets stood at $158.8 million in 2022, then rose by 16.77% to $185.5 million in 2023, then fell by 5.45% to $175.4 million in 2024, then decreased by 7.99% to $161.3 million in 2025, then advanced by 1.27% to $163.4 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $163.4 million, $155.6 million, and $161.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.